World's first medical networking and resource portal

News & Highlights
Please make use of the search function to browse preferred content
Medical News & Updates
Dec 08
Brain scan after mild stroke can predict future risk
A brain scan within 24 hours of a mild, non-disabling stroke, can predict when patients will be at the highest risk of another stroke or when symptoms may worsen, says a study.

Like stroke, a transient ischemic attack (TIA) is caused by restricted blood supply to the brain. Symptoms may last only a few minutes.

"All patients should get a CT scan of their brain after a TIA or non-disabling stroke," said the study's co-senior author Jeffrey Perry, an associate professor of emergency medicine at the University of Ottawa in Canada.

"Images can help healthcare professionals identify patterns of damage associated with different levels of risk for a subsequent stroke or help predict when symptoms may get worse," Perry added.

For the study, the researchers tracked more than 2,028 patients who received CT scans within 24 hours of a TIA. The scans revealed that 40 percent of them had brain damage due to impaired circulation (ischemia).

Compared to patients without ischemia, the probability of another stroke occurring within 90 days of the initial episode was 2.6 times greater if the CT image revealed newly damaged tissue due to poor circulation (acute ischemia).

The researchers found that higher the damage to the brain, greater was the risk of another stroke within 90 days, making the scans a useful prediction tool.

The study appeared in the journal Stroke.

Dec 06
Poisonous mushrooms could help cure deadly diseases
Toxic mushrooms may hold secrets to tackling deadly diseases as researchers have discovered that the fungi could help in the production of medicines capable of curing disease without the patient suffering any side effects.

The researchers discovered in mushrooms an enzyme called POPB that create the mushroom's molecules that harbour missile-like proficiency in attacking and annihilating a single vulnerable target in the human liver.

These findings could lead to single-minded medicines with zero side effects, said co-lead author Jonathan Walton, professor of plant biology at the Michigan State University in the US.

The team revealed how the enzyme contributes to the manufacture of chemical compounds known as cyclic peptides, a favourite molecule that pharmaceutical companies use to create new drugs.

"Mushrooms are prolific chemical factories, yet only a few of their peptides are poisonous," he added.

"These toxins survive the high temperatures of cooking and the acids of digestion, and yet they are readily absorbed by the bloodstream and go directly to their intended target. These are the exact qualities needed for an effective medicine," Walton said.

The enzyme POPB convert the toxins from their initial linear shape into cyclic peptides, fortress-like molecular circles comprising eight amino acids.

Harnessing the distinct properties of POPB will allow scientist to create billions of variant molecules, which can be tested against many different medical targets such as pathogenic bacteria and cancer, the researchers said.

For the study, the scientists worked with the mushroom species Amanita.

The study appeared in the journal Chemistry and Biology.

Dec 05
Protein responsible for sense of touch identified
Solving a neuroscience mystery, researchers, including Indian-origin scientist Sanjeev Ranade, have identified the protein receptor that mediates the sense of touch in mammals.

"We can say with certainty that Piezo2 is the principal touch sensor in mammals," said Ardem Patapoutian, professor at The Scripps Research Institute (TSRI) at La Jolla in California.

Mice that lack the Piezo2 ion-channel protein in their skin cells and nerve endings lose nearly all their sensitivity to ordinary light touch, the researchers discovered.

"Across a range of tests, we observed a dramatic reduction in their responsiveness to ordinary light touch stimuli," said Ranade, postdoctoral fellow at TSRI and lead author of the study.

Ranade accomplished the tricky task of deleting the Piezo2 gene from mice to observe whether the animals still responded normally to touch stimuli.

Remarkably, these touch-insensitive mice remained responsive to skin-applied stimuli that are normally painful, such as heat, cold and pinching.

Painful mechanical sensations such as pinching are thought to be mediated by different nerve terminals, which require more force to activate.

The finding suggests that the detection of light, innocuous touch, which we commonly think of as the "sense of touch", is mediated principally by one set of nerve ends using piezo2 ion channels.

By contrast, stronger, pain-causing touch sensations appear to be mediated by a less force-sensitive set of nerve ends with their own ion channel proteins, which have yet to be discovered.

The study appeared in the journal Nature.

Dec 04
Mediterranean diet key to longer, healthier life
Consuming a Mediterranean diet can lead to a longer, healthier life, says a new study.

According to the scientists, the combination of fruit and vegetables, nuts, legumes, olive oil and a glass of wine can help reverse the ageing process by slowing down the damage to chromosomes linked to ageing, and offer a health advantage, staving off killer diseases, the Daily Express reported.

The study analysed data on 4,676 healthy middle-aged women, and found that Mediterranean diet had anti-oxidant and anti-inflammatory effects, that stops the shortening of telomeres, which is associated with lower life expectancy and a greater risk of age-related diseases.

However, none of the individual dietary components was associated with telomere length.

The diet has a host of health benefits, including slashing the risk of death and chronic diseases from heart conditions and Alzheimer's to cancer and diabetes, and Gaynor Bussell, a dietitian and public health nutritionist, said the research showed that there were no "superfoods" and maybe not even foods that were good or bad.

The findings are published in the British Medical Journal.

Dec 03
Muscles gene map to help diagnose diseases
Researchers have created a comprehensive overview of how thousands of genes interact in relation to the behaviour of muscles, thereby offering new insights into the biological mechanism that is at the root of a disease.

To begin with, for examining muscle genes that are involved in the carbohydrate metabolism, the data may help direct the development of medicine to help against diabetes.

The study compares the reactions of all genes in the muscles exposed to diverse muscular work with muscles that lack activity.

This was been achieved partly by means of taking muscle tissue samples from twenty young, healthy male participants, and partly by means of genetic screening.

The results represent an enormous volume of data which is now available to researchers all over the world.

"Genetic screening faces a major challenge in that tens of thousands of genes multiplied by a given number of test subjects involved and by a given number of points in time selected for measurement, quickly develops into hundreds of thousands of data points that you have to be able to comprehend and interpret," said Kristian Vissing from Aarhus University in Denmark.

"We have, therefore, developed a search tool which makes it easy for other researchers to find their way around the large volumes of data and obtain knowledge about the genes they are particularly interested in," Kristian Vissing added.

The study appeared in the journal Scientific Data.

Dec 02
Vegetable oil component helps combat gastric ulcers
Linolenic acid, a component of vegetable oils, is key to destroying the bacteria strongly associated with gastric ulcers and cancer, a new study says.

The findings could lead to new treatment for gastric diseases.

"Current Helicobacter pylori bacterium treatments are facing a major challenge - antibiotic resistance," said Liangfang Zhang, professor at the University of California` San Diego School of Medicine.

"Our goal was to develop a nanotherapeutic that can tolerate the harsh gastric environment, kill H. pylori and avoid resistance," Zhang added.

To combat the infection caused by Helicobacter pylori the researchers developed LipoLLA, a therapeutic nanoparticle that contains the vegetable oil component linolenic acid.

In mice, LipoLLA was safe and more effective against the infection than standard antibiotic treatments.

What is more, LipoLLA was not toxic to the mice and the bacteria did not develop resistance to the therapy.

"This is the first step to verify that we can make this therapeutic nanoparticle and demonstrate that it works to reduce H. pylori colonisation. We are now working to further enhance the particle, making it more stable and more effective," Zhang said.

The findings appeared in the journal Proceedings of the National Academy of Sciences.

Dec 01
Experimental vaccine slows progress of breast cancer
An experimental breast cancer vaccine has been showing progress in slowing down the development of disease in patients.

Out of 14 women with advanced breast cancer who received the drug, half showed no sign of tumor growth a year after treatment, the Daily Express reported.

The vaccine had an effect even in those with immune systems weakened by the disease and chemotherapy.

The vaccine primes the immune system to target mammaglobin-A, a protein found almost exclusively in breast tissue. Breast cancer tumors produce it at abnormally high levels.

The scientists stated that the vaccine would not be effective in cancer patients with tumors that do not generate mammaglobin-A.

The research is published in the journal Clinical Cancer Research.

Browse Archive